Finasteride Plus 1 — Class I drug recall D-1269-2020
Terminated recall by MasterPharm LLC, reported 2020-05-20, distributed nationwide. Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.
| Recall number | D-1269-2020 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | MasterPharm LLC, South Richmond Hill, NY, United States |
| Recall initiated | 2020-04-14 |
| Classified | 2020-05-19 |
| Reported by FDA | 2020-05-20 |
| Terminated | 2023-09-07 |
| Distributed | Nationwide (US) |
| Quantity | 7,260 capsules |
| Expiration dates | 2020-08-25 |
Product
Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.
Reason for recall
Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1269-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.